Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MEDTRONIC PLC

(MDT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Medtronic : Radial Artery Access Portfolio Granted CE Mark

09/28/2021 | 03:43am EDT


© MT Newswires 2021
All news about MEDTRONIC PLC
10/15MEDTRONIC PLC : Regulation FD Disclosure (form 8-K)
AQ
10/13OPSENS : Says "Successfully Treats" First Patients in Human Clinical Study for TAVR Proced..
MT
10/12MEDTRONIC : Sets New ESG Targets
MT
10/12MEDTRONIC : announces new ESG targets in its FY21 Integrated Performance Report and unveil..
PR
10/12MEDTRONIC : Hugo Robotic-Assisted Surgery System Receives European CE Mark Approval
AQ
10/11MEDTRONIC : Hugo Robotic-Assisted Surgery System Receives European CE Mark Approval
MT
10/11MEDTRONIC : Hugo™ Robotic-Assisted Surgery System Receives European CE Mark Approval
PR
10/11Medtronic plc Receives CE Mark for the Hugo Robotic-Assisted Surgery System
CI
10/05MEDTRONIC : Continuous Rhythm Monitoring Reveals Strong Short-Term Risk Association Betwee..
AQ
10/04Medtronic to Seek Acquisitions
CI
More news
Analyst Recommendations on MEDTRONIC PLC
More recommendations
Financials (USD)
Sales 2022 32 994 M - -
Net income 2022 5 617 M - -
Net Debt 2022 20 291 M - -
P/E ratio 2022 32,2x
Yield 2022 1,88%
Capitalization 172 B 172 B -
EV / Sales 2022 5,83x
EV / Sales 2023 5,47x
Nbr of Employees 90 000
Free-Float 99,7%
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MDT | IE00BTN1Y115 | MarketScreener
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 29
Last Close Price 127,75 $
Average target price 145,70 $
Spread / Average Target 14,1%
EPS Revisions
Managers and Directors
Geoffrey Straub Martha Chairman & Chief Executive Officer
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Laura Mauri Chief Clinical & Regulatory Officer, Senior VP
Richard E. Kuntz Chief Medical & Scientific Officer, Senior VP
Gregory L. Smith Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capi. (M$)
MEDTRONIC PLC9.06%171 927
ABBOTT LABORATORIES7.31%208 288
BECTON, DICKINSON AND COMPANY-3.62%69 259
HOYA CORPORATION20.71%55 655
DEXCOM, INC.47.27%52 677
SARTORIUS STEDIM BIOTECH60.65%50 025